搜尋結果
《大行》美銀證券升中生製藥(01177.HK)目標價至3.8元 評級「買入」
AASTOCKS via Yahoo財經香港· 4 日前美銀證券發表研究報告引述,中生製藥(01177.HK)今年3月涉及帶量採購(VBP)藥物銷售額表現。當中,氟比洛芬(flurbiprofen)按年跌6%,按季升35.1%;骨化三醇 ...
TechCrunch podcasts roundup: Bill Gates on climate, the current health of fintech, and Latashá ...
TechCrunch· 6 日前TechCrunch is more than just a site with words. Embedded below are the latest from the TechCrunch Podcast from Darrell who ...